Search

everythinglearnresearchcommunity

for

Search:↓

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Tamoxifen effectively treats gynecomastia without causing impotence.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Older rats more affected by minoxidil's cardiotoxic effects than younger rats.

Finasteride raises suicide-linked aggression and stops clozapine's positive effects in schizophrenia animals.

A three-year-old girl survived a rare serious infection caused by BCG vaccination, which improved after treatment with a leprosy drug.

Leflunomide is more likely to help treat alopecia areata than cause it.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Lecithin organogels could be good for applying drugs to the skin because they are stable, safe, and can improve drug absorption.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Technique creates 3D cell spheroids for hair-follicle regeneration.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

New methods like nanoparticles and microneedles show promise for better skin drug delivery, especially for hair disorders.

Recent advances in hair loss treatments show significant progress.

Green tea may help with skin health and protect against UV damage, but more research is needed to confirm its safety and effectiveness.

Minoxidil treatment may cause hair loss.

Jujube fruit extract may reduce kidney damage from ibuprofen in rats.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

Finasteride interacts with terazosin, but not doxazosin; caution needed.

Deformable vesicular carriers improve drug delivery for skin conditions and systemic treatments.

Finasteride affects the male rat brain by reducing certain protein activation, but these effects may reverse after stopping the drug.

Liposome-based systems improve skin wound healing effectively.